Company Filing History:
1 out of 11 
1 out of 1 
1 out of 1 Years Active: 2020-2025
Title: Csaba Pál: Innovator in Molecular Biology
Introduction
Csaba Pál is a notable inventor based in Szeged, Hungary. He has made significant contributions to the field of molecular biology, particularly in the development of novel compounds and methods for treating bacterial infections. With a total of 2 patents, his work has implications for both human and veterinary medicine.
Latest Patents
One of Csaba Pál's latest patents is focused on a class of DNA gyrase and/or topoisomerase IV inhibitors that exhibit activity against both gram-positive and gram-negative bacteria. This invention relates to compounds with a specific structural formula, processes for their preparation, and pharmaceutical compositions that utilize these compounds as active ingredients. The patent emphasizes their use as medicaments for treating bacterial infections in humans and warm-blooded animals.
Another significant patent involves a method for mutagenizing intracellular nucleic acids. This innovative approach allows for in vivo mutagenesis of a preselected target region of intracellular DNA within a cell culture. The method utilizes a pool of partially overlapping single-stranded DNA oligonucleotides that form a continuous sequence complementary to a sequence of interest. This technique enables the production of a cell library with a repertoire of variant cells, covering point mutations at every position within the target region.
Career Highlights
Throughout his career, Csaba Pál has worked with esteemed institutions such as the University of Ljubljana and the Szeged Biological Research Center. His research has contributed to advancements in molecular biology and has garnered attention in the scientific community.
Collaborations
Csaba has collaborated with notable colleagues, including Tihomir Tomašič and Nace Zidar. These partnerships have further enriched his research endeavors and have led to impactful innovations in the field.
Conclusion
Csaba Pál's contributions to molecular biology through his patents and collaborations highlight his role as an innovator in the scientific community. His work continues to influence the development of new therapeutic strategies for combating bacterial infections.